We then challenged K562 and KBM5, two CML cell lines harboring the fusion gene BCR::ABL1, with IM, which specifically inhibits the tyrosine kinase activity of BCR::ABL1. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.